Serina sells AgeX assets to shareholder Juvenescence to become debt-free

Fecha de publicación: 15/01/2025
Fuente: FierceBiotech
Serina Therapeutics is shedding a subsidiary to start the new year off debt-free. The Alabama-based biotech has sold UniverXome Bioengineering to clear away $11.2 million in debt.